NCT00320307View on ClinicalTrials.gov

Comparison of Abacavir Following Once-Daily And Twice-Daily Administration In HIV Infected Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 30, 2005

Conditions
HIV Infection
Interventions
DRUG

abacavir

Trial Locations (1)

SW10 9TH

GSK Investigational Site, London

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY